Pantago‑40 Tablets are single-agent proton pump inhibitor tablets containing Pantoprazole Sodium IP equivalent to 40 mg of Pantoprazole. Designed for effective long-term acid suppression, this formulation is suitable for treating acid-related disorders including GERD, peptic ulcers, and gastritis.
Main Benefits:
-
Reduces gastric acid secretion by suppressing proton pump activity for extended duration
-
Provides symptomatic relief from heartburn, acid reflux, and epigastric discomfort
-
Enhances ulcer healing and prevents recurrence
Indications:
-
Gastroesophageal reflux disease and erosive esophagitis
-
Duodenal and gastric ulcers
-
Zollinger–Ellison syndrome
-
Acid-related dyspepsia
Administration:
One tablet daily, preferably before the first meal. Therapy duration varies (2–8 weeks) depending on condition severity. Maintenance dosing may be advised for chronic cases.
Contraindications & Precautions:
-
Not suitable for pregnancy unless essential
-
Monitor magnesium levels if used long-term
-
May interact with drugs requiring gastric acidity for absorption
Storage Guidance:
Store below 25 °C in a dry place. Keep out of reach of children.
